Annual Revenue
$420.00 K
NaN%
December 31, 2023
Summary
- As of February 7, 2025, CYCC annual revenue is $420.00 thousand
- CYCC annual revenue is now -99.99% below its all-time high of $7.23 billion, reached on January 1, 1994.
Performance
CYCC Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$10.00 K
+$6000.00+150.00%
September 30, 2024
Summary
- As of February 7, 2025, CYCC quarterly revenue is $10.00 thousand, with the most recent change of +$6000.00 (+150.00%) on September 30, 2024.
- Over the past year, CYCC quarterly revenue has dropped by -$21.00 thousand (-67.74%).
- CYCC quarterly revenue is now -98.64% below its all-time high of $735.00 thousand, reached on September 30, 2014.
Performance
CYCC Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$74.00 K
-$6000.00-7.50%
September 30, 2024
Summary
- As of February 7, 2025, CYCC TTM revenue is $74.00 thousand, with the most recent change of -$6000.00 (-7.50%) on September 30, 2024.
- Over the past year, CYCC TTM revenue has dropped by -$346.00 thousand (-82.38%).
- CYCC TTM revenue is now -96.19% below its all-time high of $1.94 million, reached on December 31, 2015.
Performance
CYCC TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
CYCC Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -67.7% | -82.4% |
| 3 y3 years | - | - | - |
| 5 y5 years | +180.0% | - | - |
CYCC Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -97.3% | +150.0% | -83.5% | at low |
| 5 y | 5-year | at high | at low | -97.3% | +150.0% | -83.5% | at low |
| alltime | all time | -100.0% | +1300.0% | -98.6% | +102.3% | -96.2% | +469.2% |
Cyclacel Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $10.00 K(+150.0%) | $74.00 K(-7.5%) |
| Jun 2024 | - | $4000.00(-86.2%) | $80.00 K(-82.2%) |
| Mar 2024 | - | $29.00 K(-6.5%) | $449.00 K(+6.9%) |
| Dec 2023 | $420.00 K(+180.0%) | $31.00 K(+93.8%) | $420.00 K(+8.0%) |
| Sep 2023 | - | $16.00 K(-95.7%) | $389.00 K(+4.3%) |
| Jun 2023 | - | $373.00 K(+148.7%) | $373.00 K(+148.7%) |
| Dec 2018 | $150.00 K(-82.2%) | $150.00 K(-45.8%) | $150.00 K(-82.2%) |
| Dec 2016 | $843.00 K(-56.6%) | $277.00 K(+35.1%) | $843.00 K(-14.6%) |
| Sep 2016 | - | $205.00 K(-7.7%) | $987.00 K(-34.1%) |
| Jun 2016 | - | $222.00 K(+59.7%) | $1.50 M(-4.7%) |
| Mar 2016 | - | $139.00 K(-67.0%) | $1.57 M(-19.2%) |
| Dec 2015 | $1.94 M(+12.1%) | $421.00 K(-41.1%) | $1.94 M(+9.8%) |
| Sep 2015 | - | $715.00 K(+141.6%) | $1.77 M(-1.1%) |
| Jun 2015 | - | $296.00 K(-42.2%) | $1.79 M(-3.2%) |
| Mar 2015 | - | $512.00 K(+107.3%) | $1.85 M(+6.7%) |
| Dec 2014 | $1.73 M(+60.0%) | $247.00 K(-66.4%) | $1.73 M(-2.9%) |
| Sep 2014 | - | $735.00 K(+106.5%) | $1.79 M(+31.3%) |
| Jun 2014 | - | $356.00 K(-10.1%) | $1.36 M(+7.3%) |
| Mar 2014 | - | $396.00 K(+32.4%) | $1.27 M(+17.0%) |
| Dec 2013 | $1.08 M(+1471.0%) | $299.00 K(-3.2%) | $1.08 M(+37.2%) |
| Sep 2013 | - | $309.00 K(+17.0%) | $790.00 K(+52.2%) |
| Jun 2013 | - | $264.00 K(+24.5%) | $519.00 K(+84.7%) |
| Mar 2013 | - | $212.00 K(+4140.0%) | $281.00 K(+307.2%) |
| Dec 2012 | $69.00 K(-38.4%) | $5000.00(-86.8%) | $69.00 K(+7.8%) |
| Sep 2012 | - | $38.00 K(+46.2%) | $64.00 K(+146.2%) |
| Jun 2012 | - | $26.00 K(-84.5%) | $26.00 K(-68.7%) |
| Jun 2011 | - | $168.00 K(-12.5%) | $83.00 K(+144.1%) |
| Mar 2011 | - | $192.00 K(-144.0%) | $34.00 K(-69.9%) |
| Dec 2010 | $112.00 K(-87.7%) | -$436.00 K(-374.2%) | $113.00 K(-84.6%) |
| Sep 2010 | - | $159.00 K(+33.6%) | $736.00 K(-8.8%) |
| Jun 2010 | - | $119.00 K(-56.1%) | $807.00 K(-15.4%) |
| Mar 2010 | - | $271.00 K(+44.9%) | $954.00 K(+4.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $911.00 K(+3.9%) | $187.00 K(-18.7%) | $911.00 K(-6.6%) |
| Sep 2009 | - | $230.00 K(-13.5%) | $975.00 K(-3.8%) |
| Jun 2009 | - | $266.00 K(+16.7%) | $1.01 M(+9.3%) |
| Mar 2009 | - | $228.00 K(-9.2%) | $928.00 K(+5.8%) |
| Dec 2008 | $877.00 K(+579.8%) | $251.00 K(-6.7%) | $877.00 K(+37.5%) |
| Sep 2008 | - | $269.00 K(+49.4%) | $638.00 K(+58.7%) |
| Jun 2008 | - | $180.00 K(+1.7%) | $402.00 K(+58.9%) |
| Mar 2008 | - | $177.00 K(+1375.0%) | $253.00 K(+97.7%) |
| Dec 2007 | $129.00 K(-66.7%) | $12.00 K(-63.6%) | $128.00 K(-45.1%) |
| Sep 2007 | - | $33.00 K(+6.5%) | $233.00 K(-17.7%) |
| Jun 2007 | - | $31.00 K(-40.4%) | $283.00 K(-1.7%) |
| Mar 2007 | - | $52.00 K(-55.6%) | $288.00 K(-25.6%) |
| Dec 2006 | $387.00 K(+8.7%) | $117.00 K(+41.0%) | $387.00 K(+13.8%) |
| Sep 2006 | - | $83.00 K(+130.6%) | $340.00 K(-18.3%) |
| Jun 2006 | - | $36.00 K(-76.2%) | $416.00 K(-7.8%) |
| Mar 2006 | - | $151.00 K(+115.7%) | $451.00 K(+26.7%) |
| Dec 2005 | $356.00 K(+474.2%) | $70.00 K(-56.0%) | $356.00 K(+19.1%) |
| Sep 2005 | - | $159.00 K(+123.9%) | $299.00 K(+95.4%) |
| Jun 2005 | - | $71.00 K(+26.8%) | $153.00 K(+44.3%) |
| Mar 2005 | - | $56.00 K(+330.8%) | $106.00 K(+71.0%) |
| Dec 2004 | $62.00 K(-63.5%) | $13.00 K(0.0%) | $62.00 K(-16.2%) |
| Sep 2004 | - | $13.00 K(-45.8%) | $74.00 K(-44.8%) |
| Jun 2004 | - | $24.00 K(+100.0%) | $134.00 K(-20.7%) |
| Mar 2004 | - | $12.00 K(-52.0%) | $169.00 K(-0.6%) |
| Dec 2003 | $170.00 K(+466.7%) | $25.00 K(-65.8%) | $170.00 K(+17.2%) |
| Sep 2003 | - | $73.00 K(+23.7%) | $145.00 K(+101.4%) |
| Jun 2003 | - | $59.00 K(+353.8%) | $72.00 K(+453.8%) |
| Mar 2003 | - | $13.00 K | $13.00 K |
| Dec 2001 | $30.00 K(-69.4%) | - | - |
| Dec 2000 | $98.00 K(-100.0%) | - | - |
| Jan 1994 | $7.23 B(+2.1%) | - | - |
| Jan 1993 | $7.08 B | - | - |
FAQ
- What is Cyclacel Pharmaceuticals annual revenue?
- What is the all time high annual revenue for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals quarterly revenue year-on-year change?
- What is Cyclacel Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Cyclacel Pharmaceuticals?
- What is Cyclacel Pharmaceuticals TTM revenue year-on-year change?
What is Cyclacel Pharmaceuticals annual revenue?
The current annual revenue of CYCC is $420.00 K
What is the all time high annual revenue for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high annual revenue is $7.23 B
What is Cyclacel Pharmaceuticals quarterly revenue?
The current quarterly revenue of CYCC is $10.00 K
What is the all time high quarterly revenue for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high quarterly revenue is $735.00 K
What is Cyclacel Pharmaceuticals quarterly revenue year-on-year change?
Over the past year, CYCC quarterly revenue has changed by -$21.00 K (-67.74%)
What is Cyclacel Pharmaceuticals TTM revenue?
The current TTM revenue of CYCC is $74.00 K
What is the all time high TTM revenue for Cyclacel Pharmaceuticals?
Cyclacel Pharmaceuticals all-time high TTM revenue is $1.94 M
What is Cyclacel Pharmaceuticals TTM revenue year-on-year change?
Over the past year, CYCC TTM revenue has changed by -$346.00 K (-82.38%)